Laparoscopic parenchyma-sparing pancreatectomy safe and feasible approach for Solid pseudopapillary tumor Dr. Shravani Dali30 May 2023 2:30 PM GMTSolid pseudopapillary tumor (SPT) of the pancreas is a rare low-grade malignant tumor. Here, we aimed to determine the safety and feasibility of...
Medical Bulletin 28/January/2023 Isra Zaman28 Jan 2023 10:00 AM GMTHere are the top medical news for the day:Immune response to COVID-19 strengthens over time: StudyImmunity from COVID-19 appears to gather strength...
Persistent mutations in tumors may predict immunotherapy response: Study Isra Zaman28 Jan 2023 4:00 AM GMTIinvestigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg Kimmel Institute for Cancer Immunotherapy have found that a subset of...
Predicting side-effects and cancer's return in patients treated with immunotherapy by novel experimental test Isra Zaman16 Sep 2022 4:00 AM GMTA single research test has the potential to predict which patients treated with immunotherapies –which harness the immune system to attack cancer...
Commonly used prostate cancer treatment rewires engine of prostate tumors: Research Isra Zaman16 Sep 2022 3:45 AM GMTDrugs like enzalutamide that inhibit male hormones from activating the androgen receptor have been used to treat advanced prostate cancer for more...
Sub-lobar surgery new standard of treatment for non-small cell lung cancer Dr. Kamal Kant Kohli9 Aug 2022 2:30 PM GMTResearchers have found in a large international study that sub lobar surgery among patients with non-small cell lung cancer tumors that are two...
FDA Approves First Targeted Therapy for HER2-Low Breast Cancer Dr. Kamal Kant Kohli6 Aug 2022 2:30 AM GMTThe U.S. Food and Drug Administration has approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with...
MRI guided high-intensity focused ultrasound can control prostate cancer with fewer side effects: Lancet Dr. Kamal Kant Kohli26 Jun 2022 2:30 PM GMTIn recent years, a new treatment strategy known as focal therapy (partial gland ablation) has emerged for prostate cancer considered to be...
USFDA nod to Novartis Tafinlar plus Mekinist for solid tumors with gene mutation Ruchika Sharma23 Jun 2022 9:17 AM GMTBRAF V600E is the most common type of BRAF mutation, accounting for up to 90% of BRAF-mutant cancers.
Probiotic bacteria may enhance tamoxifen effectiveness in treatment of ER+ breast cancer Dr. Kamal Kant Kohli22 Jun 2022 2:15 PM GMTProbiotic bacteria may enhance anti-cancer activities of the breast cancer drug tamoxifen and other endocrine-targeted therapies, which could help...
First Mutation-Targeted Bladder Cancer Drug May Be Under-Used Dr. Kamal Kant Kohli19 May 2022 2:30 PM GMT PHILADELPHIA: The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy...
New CAR T-cell therapy for solid tumors was safe and showed early efficacy Dr. Kamal Kant Kohli29 April 2022 3:30 AM GMTNEW ORLEANS: A new chimeric antigen receptor (CAR) T-cell product had an acceptable safety profile and showed early signs of efficacy as a monotherapy...
